Central Laboratories Applications & Studies
-
Efficient Data Aggregation & Oversight: A CRO Success Story
4/22/2024
Explore how a full-service CRO & tech-driven life sciences provider streamlined data aggregation & clinical trial oversight, yielding significant time and cost savings.
-
Breaking The Mold: How R Is Revolutionizing CSR Generation
4/22/2024
The open-source statistical programming language R is becoming more popular in the life sciences sector for clinical study report submissions due to its cost-effectiveness, inclusivity, and collaboration.
-
Cutting Red Tape: Direct Data Capture In Clinical Trials
4/12/2024
Say goodbye to duplicate work in clinical trials. Discover how Direct Data Capture revolutionizes research, benefiting patients, sponsors, and sites while streamlining processes.
-
Patient Caregiver Network Improves Post-Seizure Trial Data
3/26/2024
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
Rare Disease Prioritization Model And Landscape Analysis
3/15/2024
Uncover how a global pharmaceutical company seeking to identify promising indications among rare diseases to develop preclinical candidate molecules received an in-depth disease analysis to guide its strategic decision-making.
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
2/6/2024
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
Showcasing Advances In CAR-T Research At The 65th ASH Annual Meeting
1/18/2024
Take a look at three research posters presented at the 65th American Society of Hematology (ASH) annual meeting, emphasizing the impact of academic-industry collaborations on CAR-T therapy.
-
Unified Platform Supports Rapid Implementation Of Rescue Study
1/17/2024
Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.
-
eSource For A COVID Treatment Trial
1/17/2024
Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
1/16/2024
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.